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Some outbreaks involving highly pathogenic avian influenza viruses (HPAIV) of subtypes H5 and H7 were caused by
avian-to-human transmissions. In nature, different influenza A viruses can reassort leading to new viruses with new
characteristics. We decided to investigate the impact that the NS-segment of H5 HPAIV would have on viral
pathogenicity of a classical avian H7 HPAIV in poultry, a natural host. We focussed this study based on our previous
work that demonstrated that single reassortment of the NS-segment from an H5 HPAIV into an H7 HPAIV changes
the ability of the virus to replicate in mammalian hosts. Our present data show that two different H7-viruses
containing an NS-segment from H5–types (FPV NS GD or FPV NS VN) show an overall highly pathogenic phenotype
compared with the wild type H7–virus (FPV), as characterized by higher viral shedding and earlier manifestation
of clinical signs. Correlating with the latter, higher amounts of IFN-β mRNA were detected in the blood of
NS-reassortant infected birds, 48 h post-infection (pi). Although lymphopenia was detected in chickens from all AIV-
infected groups, also 48 h pi those animals challenged with NS-reassortant viruses showed an increase of peripheral
monocyte/macrophage-like cells expressing high levels of IL-1β, as determined by flow cytometry. Taken together,
these findings highlight the importance of the NS-segment in viral pathogenicity which is directly involved in
triggering antiviral and pro-inflammatory cytokines found during HPAIV pathogenesis in chickens.Introduction
In recent decades highly pathogenic avian influenza vi-
ruses (HPAIV) belonging to H5– and H7- subtypes have
been reported to cause major outbreaks in birds world-
wide [1]. The overall impact in the poultry industry has
dramatically increased in the last decade, from 23 million
birds affected between 1959 and 1998 to more than 200
million, between 1999 and 2004 [2]. Besides their eco-
nomic consequences, influenza A viruses (IAV) are cur-
rently considered as one of the most important threats to
human health because of their pandemic potential, under-
lining the relevance of avian reservoirs for IAV. Since* Correspondence: vergaraa@staff.uni-marburg.de
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distribution, and reproduction in any medium2003, as confirmed by the World Health Organisation,
transmissions of the H5N1 HPAIV to humans have caused
approximately 628 disease cases and 374 deaths [3]. More
recently, last March 2013, a novel influenza A/H7N9 virus
was identified in humans. The A/H7N9 virus originates
from multiple reassortment events of influenza viruses of
avian origin; ducks and chickens have been suggested as
intermediate hosts which led to the emergence of A/
H7N9 [4].Therefore, it is important to increase our know-
ledge concerning the role of viral determinants in viru-
lence and in different species to improve vaccine design
and therapies against IAV.
The innate immune response is the first unspecific bar-
rier of the host against pathogens, and the induction of
type I interferon (IFN) expression, mainly IFNα/β, is one
of the earliest anti-viral cytokines expressed upon IAV in-
fection [5]. Although hosts develop antiviral responses in
order to control the infection, IAV have evolved multiple
strategies to avoid these responses [6]. By expressing theentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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mune response of infected cells, especially limiting the
production of type I IFN, as well as that of other immuno-
modulators [7]. IFN-β induction can be limited by the
NS1 protein by both pre-transcriptional (cytoplasmatic)
and post-transcriptional (nuclear) processes [8,9]. How-
ever, the mechanisms and targets for NS1 depend on virus
strain [9,10]. Furthermore, it has been demonstrated that
the NS1 protein prevents virus-mediated activation of the
following transcription factors: interferon regulatory tran-
scription factor (IRF)-3 [11], nuclear factor kappa-light-
chain-enhancer of activated B cells (NFκB) [12] and c-Jun/
ATF-2 [13], which are essential for IFN-β induction. The
contribution of the NS1 protein to the pathogenicity of
IAV has been demonstrated in mammalian models, such
as mice and pigs [14-16]. Although less is known in avian
species, Li et al. reported that, as in mammals, in both
chickens and geese NS1 has an important role in viral
virulence [17]. Many functions of the NS2 protein, which
is translated from the eighth RNA segment (the same gen-
ome segment as for the NS1 protein), are, however, not
understood. Its role in mediating the export of vRNP from
the nucleus to the cytoplasm is well studied [18].
Pro-inflammatory cytokines secreted during IAV infec-
tion have also been described to have an important role in
mammalian species [19,20]. In a mouse model, lymphocyte
apoptosis and high-level inductions of cytokines, including
interleukin 1 (IL-1), have been proposed to contribute to
the severity of IAV [21]. Little is known, however, about
the role of IL-1 in chickens, the natural host of IAV. Thus,
further studies about the role of pro-inflammatory cyto-
kines in disease severity and outcomes in chickens infected
with HPAIV are needed.
The present study was designed to determine the impact
that an NS-segment reassortment between two HPAIV
would have on the pathogenicity of IAV. The role of the
NS-segment was assessed using a recombinant H7N1 virus
(A/FPV/Rostock/34; FPV) with NS segments from H5N1
viruses: A/Goose/Guangdong/1/96 (GD) or A/Viet Nam/
1203/2004 (VN) previously generated by reverse genetics.
The new viruses are named FPV NS GD and FPV NS VN,
respectively. We show that NS segments from the H5-type
HPAIV can alter the pathogenicity of FPV in chickens by
increasing clinical manifestations. Interestingly, the ex-
change of NS segments also modifies the host antiviral
response, as demonstrated by an increase in IL-1β produc-
tion in both FPV NS- GD and -VN infected chickens, as
early as 2 days after infection.
Materials and methods
Cell culture and viruses
Madin-Darby Canine Kidney (MDCK) cells were pur-
chased from ATCC (CCL-34) and cultured according to
the manufacturer’s instructions in Dulbecco’s modifiedEagle’s medium (DMEM) (Life Technologies, S.A, CA,
USA) supplemented with 10% fetal calf serum (FCS) and
antibiotics (100 U mL-1 penicillin and 0.1 mg mL-1 strepto-
mycin) at 37 °C in a 5% CO2 humidified atmosphere.
Viruses used in this study were the A/FPV/Rostock/34
(FPV; H7N1) generated by recombinant technology and
two reassortants carrying the NS-segment of either A/
Goose/Guangdong/1/96 (GD; H5N1) or A/Viet Nam/
1203/2004 (VN; H5N1) in the genetic background of
FPV. The reassortants are named FPV NS GD and FPV
NS VN, respectively. All these viruses were generated in
the facilities of the Institute of Medical Virology at
Justus-Liebig-University in Giessen (Germany), as previ-
ously described [14,22]. Virus stocks were propagated in
the allantoic cavity of 11-day-old embryonated chicken
specific-pathogen-free (SPF) eggs (Lohmann Tierzucht
GmbH, Cuxhaven, Germany) at 37 °C for 72 h. The allan-
toic fluids were harvested, aliquoted and stored at −80 °C
until use. Virus titer was determined in 11-day-old em-
bryonated chicken SPF eggs and measured as egg lethal
doses 50% (ELD50) according to the Reed and Muench
method [23].
Animal experiments
Ninety-five SPF-eggs (Lohmann Tierzucht GmbH) were
hatched under BSL-3 containment conditions at the
Centre de Recerca en Sanitat Animal (CReSA-Barcelona).
Two-week-old chickens were divided into four groups and
placed in independent negative pressure isolators. The ani-
mals were inoculated intranasally with 105.5 ELD50 of ei-
ther FPV (Group 1, n = 25), FPV NS GD (Group 2, n = 25)
or FPV NS VN (Group 3, n = 25) in a volume of 50 μL.
One group of twenty chickens was mock-infected with
PBS 1× in a volume of 50 μL and used as a negative con-
trol (Group 4). Chickens were monitored for clinical signs
and the mean clinical score, as well as mortality rate, were
recorded. Intensity of clinical signs was assessed by a
semi-quantitative scoring indicating: healthy (0), sick (1)
or severely sick (2). A scoring of (1) was given to those an-
imals showing one of the following signs, and (2) to those
showing more than one of the following signs: respiratory
involvement, depression, diarrhoea, cyanosis of the ex-
posed skin or wattles, oedema of the face and/or head,
nervous signs. According to the ethical procedures, the
animals were euthanized with intravenous administration
of sodium pentobarbital (100 mg/kg) if severe clinical
symptoms became apparent.
Ten animals per group were kept to describe the clinical
outcome and mortality rate. The other chickens (n = 15/
group) were used to obtain samples and to perform nec-
ropsies. From these animals, blood samples were obtained
from three chickens from each group at 6 h post infection
(pi) and 1, 2, 3 and 4 days post infection (dpi). Blood was
collected from the heart after anaesthetizing the animals
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mL of blood were collected in tubes containing 2 mL of
Alsever’s anticoagulant (Sigma-Aldrich, Madrid, Spain).
Oropharyngeal and cloacal swab samples (OS and CS, re-
spectively) were collected at the same time pi in DMEM
containing antimicrobial drugs (100 U mL-1 penicillin and
0.1 mg mL-1 streptomycin). Two animals from Group 4
(negative control) were also sampled at the same time
points as the other groups.
The present study was performed in strict accordance
with the Guidelines of Good Experimental Practices.
Animal procedures were approved by the Ethical and
Animal Welfare Committee of Universitat Autònoma de
Barcelona (UAB) (Protocol #DMAH-5767). Chicken ex-
periments were conducted at Biosafety Level 3 (BSL-3)
facilities of CReSA.
Histopathology and viral nucleoprotein antigen
determined by immunohistochemistry
Necropsies and tissue sampling were performed according
to a standard protocol. For histopathological analysis, col-
lected tissues were fixed in 10% neutral buffered formalin,
dehydrated and embedded in paraffin. Tissue microtome
sections (4 μm) were processed routinely for hematoxylin/
eosin (H/E) staining and immunohistochemistry (IHC) for
the detection of type A influenza virus NP. The following
tissues were examined: central nervous system (CNS),
heart, kidney, pancreas, liver, spleen, thymus and bursa of
Fabricius.
An IHC technique based on the avidin-biotin complex
immunoperoxidase system was performed as previously re-
ported [24]. Briefly, a mouse-derived monoclonal commer-
cial antibody against the nucleoprotein (NP) of influenza A
virus (IgG2a, HB65, ATCC) was used as a primary anti-
body. As a secondary antibody, a biotinylated goat anti-
mouse IgG antibody (GaMb, Dako E0433, Denmark) was
used. Finally, an avidin-biotin-peroxidase complex (Thermo
Fisher Scientific, Rockford, IL, USA) was used and the reac-
tion was developed with 3,3′-Diaminobenzidine tetrahy-
drochloride (DAB) (brown colour) (Sigma-Aldrich) at
room temperature (RT). Sections were counterstained with
Mayer’s haematoxylin. Negative controls were those tissues
from sham-inoculated animals (Group 4) and also tissues
incubated without the primary antibody. Tissues from pre-
vious experiments demonstrated to be positive against NP
by IHC were used as positive controls. To measure the ex-
tension of the staining in tissues a semi-quantitative scoring
was assessed as follows: no positive cells (−), single positive
cells (+), scattered groups of positive cells (++), and wide-
spread positivity (+++).
Virus quantification by real time RT-PCR (RRT-qPCR)
Viral RNA quantification using one step RRT-qPCR was
performed in blood and OS and CS. Viral RNA was firstextracted with Trizol (Life Technologies, S.A) obtaining
60 μL of eluted viral RNA, as described by the manufac-
turer. Briefly, after 2–3 min incubation with 0.2 mL of
chloroform, samples were centrifuged at 12 000 × g for
15 min at 4 °C. When the aqueous phase was removed and
placed into a new tube, 0.5 mL of 100% isopropanol were
added and incubated 10 min at RT. After centrifugation at
12 000 × g for 10 min at 4 °C, the RNA was washed with
1 mL of 75% ethanol, centrifuged at 7500 × g for 5 min at 4
°C and air dried for 10 min. The RNA was re-suspended in
DEPC-water and stored at −80 °C until use.
Amplification of a matrix (M) gene fragment was car-
ried out using primers, probe, One-Step RT-PCR Master
Mix Reagents (Life Technologies, S.A) and amplification
conditions as described previously by Busquets et al.
[25] in Fast7500 equipment (Life Technologies, S.A)
using 5 μL of eluted RNA in a total volume of 25 μL.
Cytokine quantification by real-time RT-PCR (RRT-qPCR)
Total RNA from the blood of three chickens per group
and per time point (6, 24 and 48 h pi) was isolated using
Trizol (Life Technologies, S.A.), as described in the previ-
ous section. The isolated RNA was reverse-transcribed
into cDNA using the High Capacity cDNA Reverse Tran-
scription kit (Life Technologies, S.A) according to the
manufacturer’s instructions.
Primers and probes for IL-1β and for the housekeeping
gene 28S, designed by Kaiser et al. [26] were used. For
IFN-β, primers and probe were designed for the IFN-β
gene sequence available at GenBank (NM_001024836).
The probe was labelled with the fluorescent reporter
dye 5-carboxyfluorescein (FAM) at the 5′-end and with
the quencher N,N,N,N’-tetramethyl-6-carboxyrhodamine
(TAMRA) at the 3′-end [5′-(FAM*)-CGCATCCTCCAA
CACCTCTT-(TAMRA)-3′].
Amplification and detection of specific products were
performed using the TaqMan Universal PCR Master Mix
(Life Technologies, S.A) with the following cycle profile:
one cycle of 50 °C for 2 min, 95 °C for 10 min and 40 cy-
cles of 95 °C for 15 s, 60 °C for 1 min, in Fast7500 equip-
ment (Life Technologies, S.A). The mRNA expression
level was calculated using the 2-ΔΔCt method [27]. The
results are expressed as fold change in comparison to a
calibrator sample (samples from non-infected chickens,
Group 4).
Isolation of mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated
from whole blood by density-gradient centrifugation using
Histopaque®-1077 (Sigma-Aldrich). The instructions from
the manufacturer were followed with some modifications.
Briefly, 4 mL of Histopaque-1077 were overlaid with 4 mL
whole anticoagulated-blood and centrifuged for 20 min
at 400 × g at RT. Following centrifugation, the opaque
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1× solution and centrifuged again for 10 min at 250 × g.
Cell numbers were calculated using a dye solution and the
cell concentration was adjusted to 107 cells/mL.
Flow cytometric analysis
Flow cytometry studies allowed separating the blood sub-
populations by size and complexity (FSC and SSC, respect-
ively); therefore, distinguishing lymphocytes, monocytes
and macrophages from histiocytes and heterophils [28]. An
allophycocyanin (APC) Antibody Conjugation Kit (Bionova
Cientifica, Madrid, Spain) was used to conjugate both IL-1β
and IFN-β purified mAb, according to the manufacturer’s
instructions. Approximately 106 PBMC per well were added
in V-bottomed 96-well plates. The cells were fixed (PBS +
2% PFA) during 15 min, washed with FACS diluent (PBS +
2% FCS) and finally, the cells were permeabilized with
200 μL of diluted detergent (saponin). Following two
washes with FACS diluent, 50 μL of either mAb IL-1β
APC-conjugated or IFN-β APC-conjugated diluted with
FACS diluent were added and incubated for 20 min. All
procedures were carried out at 4 °C. Analyses were done
using a BD FACSAria I Flow Cytometer (Becton Dickinson,
NJ, USA).
Statistical analysis
The results correspond to the Mean ± Standard Error of
the Mean (SEM) of the indicated experiments. Differ-
ences between groups were tested for significance using
the Student’s t test. Differences were considered statisti-
cally significant at P < 0.05. Statistical analyses were per-
formed using SPSS for Windows, version 17.0. The
results from Figure 1 were analyzed with GraphPad
Prisme 6 software, using the product limit method ofFigure 1 Clinical score and survival rate of SPF-chickens after infectio
NS GD or FPV NS VN. n = ten chickens per group. Average clinical signs of
measured at different time-points after infection. The results were analyzed
by the log-rank and the Gehan-Breslow-Wilcoxon tests. No statistical differeKaplan-Meier, and comparing survival curves using both
the log-rank test and the Gehan-Breslow-Wilcoxon test.
Results
NS segment from H5-type viruses increases the virulence
and shedding of H7N1 HPAIV in chickens
Although FPV is not pathogenic in mice [29,30], in chick-
ens it is considered a highly pathogenic virus [31], as also
confirmed in the present study. FPV infection resulted in
the appearance of severe clinical signs between 5 and 7 dpi
(Figure 1A), 50% mortality by day 5 pi and 70% of mor-
tality rate by the end of the experiment, at day 10 pi
(Figure 1B). Unexpectedly, the clinical signs found in FPV
NS GD infected chickens did not increase dramatically,
showing very similar disease outcome and death kinetics
when compared with FPV (Figure 1A) at the early time-
points, albeit the final mortality rate was higher, with 90%
of the infected animals being dead by day 10 pi. A more
dramatic effect was observed for the FPV NS VN reassor-
tant virus, causing more severe disease than the other two
viruses, as early as 2–3 dpi (Figure 1A), with 90% of the
deaths recorded 5 dpi and 100% mortality by day 10 pi
(Figure 1B). However, no statistical differences were ob-
served when comparing the mortality rates between groups.
Clinical signs shown in all groups were non-specific
and consisted of depression, apathy, mucous nasal dis-
charge and ruffled feathers. More severe neurological
clinical signs as torticollis and lack of coordination were
also observed. Gross lesions were observed as early as 2
dpi in FPV NS VN and started between 3 and 4 dpi in
FPV and FPV NS GD groups. The lesions were similar
between groups and consisted of conjunctivitis, multi-
focal to diffuse haemorrhages, cyanosis of the comb and
diffuse oedema. At necropsy, petechial haemorrhages onn with HPAIV. Chickens were challenged with 105.5 ELD50 of FPV, FPV
the surviving chickens (A) and survival rate (B) from each group
with the Kaplan-Meier method and the survival curves were compared
nces were observed between the survival curves.
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detected in all the infected groups. From 3 to 7 dpi,
splenomegaly and atrophy of both the thymus and bursa
of Fabricius were observed in FPV NS GD and FPV NS
VN groups (data not shown).
Tissue samples were fixed with 10% formalin and em-
bedded in paraffin for histopathological analysis. Tissue
sections were stained with H/E and avian influenza virus
(AIV)-NP was detected by IHC (Table 1, Additional file 1).
Evaluation of H/E sections from chickens sacrificed
both at 6 h pi and 1 dpi revealed no tissue damage in com-
parison to the non-infected group. Nervous system lesions
were detected as early as 3 dpi in all groups, being more
extensive in both the NS reassortant-infected groups. The
lesions in CNS consisted of multifocal areas of malacia as-
sociated with immune staining on neurons and glial cells
(Table 1). Multifocal areas of myocardial necrosis were ob-
served in birds mainly from FPV NS GD and FPV NS VN
groups from 3 dpi. The positivity to the AIV antigen ob-
served in myocytes correlated with this finding. In FPV-
infected animals these lesions were first observed at day 4
pi and only in one animal. However, one bird showed
AIV-positive myocytes 3 dpi. In all groups, slight lesions
were observed in the liver with Kupffer’s cells showing
positivity for viral antigen (Table 1). Moderate lesions were
observed in the kidney of FPV-infected birds, while more
severe lesions were observed in the reassortant-groups,
consisting of areas of tubular necrosis associated with the
presence of viral antigen. Infiltration of heterophils and
macrophages were found in the necrotic areas. Severe le-
sions were also observed in the pancreas, which from 3
dpi on showed diffuse areas of necrosis and stained for the
presence of the associated viral antigen (Table 1). Con-
cerning the lymphohematopoietic organs studied (thymus,
spleen and bursa of Fabricius) we observed moderate to
severe lymphoid depletion from day 2 pi on.
The viraemia and the shedding of the three viruses was
characterized by determining the amount of viral RNA
present in the blood (Figure 2A) and OS (Figure 2B) and
CS (Figure 2C) at early time points post infection. A quan-
titative real time RT PCR was performed from 6 h pi until
day 3 pi. Animals infected with FPV NS VN showed sig-
nificantly higher presence of viral RNA in blood and in
OS at 2 dpi compared with the FPV-group (P < 0.05). In
the FPV NS GD group, viraemia and shedding were also
higher compared with the FPV-group, but the differences
were not statistically significant when compared between
groups. No differences were observed for both NS-
reassortant groups in any of the time points.
Comparison of the transcription and expression of IL-1β
and IFN-β genes in infected-chickens
Antiviral and pro-inflammatory cytokine expressions (IFN-β
and IL-1β as representative cytokines) in the blood weresequentially studied throughout the infection. We per-
formed a relative RT-qPCR to study the changes in IFN-β
and IL-1β mRNA transcription after the infection with
IAV, using the 28S gene as the housekeeping gene.
At 48 h pi, different levels of IFN-β gene transcription
were observed between groups (Figure 3A). At this
time-point, the levels of IFN-β mRNA were higher in
FPV NS VN-infected animals, coinciding with the dis-
ease exacerbation observed. At the earlier time-point no
evident differences were detected between groups. A sig-
nificant differential IL-1β gene expression was also ob-
served between inoculated and non-inoculated groups
at 48 h pi (P < 0.05; Figure 3B), showing higher IL-1β
mRNA levels in the former. In contrast with that ob-
served for IFN-β, FPV-infected animals showed a higher
up-regulation of IL1-β compared with those infected
with the NS-recombinants. Interestingly, slight down-
regulations of IL1-β were observed in FPV- and FPV NS
GD-blood at 24 and 6 h pi, respectively, albeit these dif-
ferences were not statistically significant (Figure 3B).
IL1-β upregulation correlates with an increase in
monocyte/macrophage-like cells
Biological processes to external perturbations are regu-
lated by a complex mechanism inside cells. To understand
these processes in our in vivo model we integrated the
data obtained by measuring the levels of mRNA of both
IL-1β and IFN-β cytokines (Figure 3), and data from the
protein measurement (Figure 4) in blood samples.
To test the amount of synthesized protein, as well as the
cell population distribution after the infection, a flow
cytometry analysis was performed, allowing us to separ-
ate the blood populations by size and complexity. In-
dependently of the individual variability, blood from
NS-reassortant virus infected chickens clearly showed a
lymphocyte reduction that correlated with an increase
in the number of macrophage/monocyte-like cells that
peaked at 48 h pi Interestingly, while no evident up-
regulation of IFN-β was observed independently of the
animal group and infection time (data not shown), a dra-
matic increase of IL-1β expression was found in both
reassortant-infected groups at 48 h pi, being higher in
those animals infected with FPV NS GD (23.6% cells ex-
pressing IL-1β) (Figure 4). In contrast, at 48 h pi, chickens
infected with FPV exhibited a slight decrease (4.3%) in the
total population of IL-1β single expressing-cells com-
pared to the non-infected group (Figure 4). Thus, NS-
reassortant infected-chickens showed clinical signs from
day 2 pi, whereas in FPV-infected ones the severe clinical
signs (score = 2) were observed from day 5 pi (Figure 1).
Discussion
The pathogenic potential of some strains of IAV has been
related to multiple factors, including viral determinants
Table 1 Average distribution of AIV-nucleoprotein antigen determined by immunohistochemistry (IHC) in tissue
samples
VIRUS STRAIN Time of AIV NP antigen detection Main localization
Tissue 1 dpi 2 dpi 3 dpi 4 dpi
FPV
CNS - - + + Neurons, glial cells
Heart - + + + Myocytes
Kidney - - −/+ + Epithelialtubularcells
Pancreas - - + + Exocrine acinar cells
Liver - - + + Kupffer’s cells
Spleen - - + + Macrophages
Thymus - + + + Macrophages
Bursa of Fabricius - - + + Macrophages
FPV NS GD
CNS - - ++ + Neurons, glial cells, ependymalcells
Heart - ++ + + Myocytes, macrophages
Kidney - +++ ++ ++ Epithelial tubular cells
Pancreas - - ++ + Exocrine acinar cells
Liver - - + + Kupffer’s cells
Spleen - + + + Macrophages, Endothelial cells
Thymus - + + + Macrophages, Endothelial cells
Bursa of Fabricius - - + + Macrophages, Endothelial cells
FPV NS VN
CNS - - ++ + Neurons, glial cells, ependymalcells
Heart - ++ + + Myocytes, macrophages
Kidney - - ++ ++ Epithelial tubular cells
Pancreas - - ++ + Exocrine acinar cells
Liver - - + + Kupffer’s cells
Spleen - - + + Macrophages, Endothelial cells
Thymus - - + + Macrophages, Endothelial cells
Bursa of Fabricius - - + + Macrophages, Endothelial cells
Saline Solution
CNS - - - - -
Heart - - - - -
Kidney - - - - -
Pancreas - - - - -
Liver - - - - -
Spleen - - - - -
Thymus - - - - -
Bursa of Fabricius - - - - -
Chickens were inoculated with FPV, FPV NS GD or FPV NS VN and necropsies were performed at different time-points. The extension of the staining in tissues was
measured by a semi-quantitative score: no positive cells (−), single positive cells (+), scattered groups of positive cells (++), and widespread positivity (+++).
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most of these descriptions have been done in mammals, in
the present study we tried to extend these studies to
natural hosts of AIV. More specifically, we focused ourstudies on the understanding of the role that the AIV NS-
segment of two different H5- HPAIV strains plays during
pathogenesis in birds. To this end, an experimental infec-
tion in SPF-chickens was designed with an H7N1 HPAIV
Figure 3 Quantification of IFN-β and IL-1β gene expression in
PBMC after FPV, FPV NS GD or FPV NS VN infection. The
cytokines IFN-β (A) and IL-1β (B) mRNA gene expression profile of
PBMC were analyzed by quantitative RT-PCR. The results are
expressed as means ± SD from three experiments. Statistical
significant difference (p < 0.05) is indicated with letters. Different
letters indicate a statistical difference between groups and the same
letter means that no statistical difference was observed.
Figure 2 Detection of influenza viral RNA after infection with
FPV, FPV NS GD or FPV NS VN. Quantification of influenza viral
RNA was performed by RRT-PCR in blood (A) oropharyngeal swab
(B) and cloacal swab (C) at the time points indicated. The results are
expressed in genome equivalent copies (GEC) of plasmid per sample
and shown as means ± SD. In the case that not all the samples from
a group (3/3) are positive, the number of positive samples from the
total number of animals is indicated above each bar. Statistical
significant differences (p < 0.05) are indicated with letters. Different
letters indicate statistical difference between groups and the same
letter means that no statistical difference was observed. Samples
from animals in the negative group (G4) were all below the limit
of detection.
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H5N1 HPAIV from either GD (FPV NS GD) or VN (FPV
NS VN).
Amino acid changes in the viral hemagglutinin and
polymorphisms in the polymerase subunit have been
shown to contribute to the virulence of AIV [42]. How-
ever, among other viral proteins, NS1 is one of the major
pathogenicity factors and it mainly acts by suppressing
type I IFN-activities [8], which are the first line of hostdefence against viral infections. The role of AIV-NS1 in
pathogenesis has been investigated for decades, albeit
most of this work has been focused on understanding its
role in mammalian species. Treanor et al. reported that
efficient infection by FPV depends on the NS1 allele in-
corporated within its genome [43]; a fact more recently
confirmed by demonstrating that specific H5N1 NS-
reassortants increase the viral replication ability in mice
and a host range of FPV [14,22]. Here, these studies have
been extended to SPF-chickens, an ideal animal model
to study AIV. We show that both NS-reassortants (FPV
NS GD and FPV NS VN), which differ from the FPV in
the NS segment, also demonstrates increased virulence
in chickens. However, due to the fact that FPV is an
HPAIV strain in chickens [31], the differences observed
in this species were not as dramatic as those shown be-
fore in mice, where this virus is non-pathogenic [14].
Therefore, we could conclude that apart from its role in
Figure 4 Expression of IL-1β protein induced the following
infection with FPV, FPV NS GD or FPV NS VN in PBMC
measured by flow cytometry. Flow cytometry of PBMC of
chickens at day 2 after infection with the influenza virus. The black
population represents monocyte/macrophage-like cells and the
lymphocyte population is shown in light grey. The numbers above
the outlined areas indicate the percent of the total population
of IL-1β single expressing-cells.
Vergara-Alert et al. Veterinary Research 2014, 45:7 Page 8 of 11
http://www.veterinaryresearch.org/content/45/1/7overcoming species-specific barriers, AIV-NS also ac-
complish a very important role as a virulent factor in
avian hosts. The differences observed in the in vivo
pathogenesis of the FPV, FPV NS GD and FPV NS VN
seem to correlate with the differential level of NS1 pro-
tein expression, at least as shown by in-cell Western blot
using MDCK cell extracts infected with the different re-
combinant viruses [22].
Amino acid differences or substitutions in the NS1
protein are described to alter its subcellular localization
[44,45]. This was recently confirmed for the NS1-
sequences for the viruses used here [14,22]. As such, the
comparison of the NS1 amino acid sequences of the vi-
ruses used in the present study showed that the residues
217 and 221 in the nuclear localisation signal 2 (NLS2) of
FPV NS VN were different or deleted, respectively, com-
pared to the NLS2 of FPV and FPV NS GD. Moreover, the
nuclear export signal (NES) of FPV NS GD presents some
amino acid differences compared to the other two viruses.
An additional Figure shows this in more detail (Additional
file 2). The differences found, affecting either NLS2 and/or
NES, could explain the differential localization of each
NS1 within the infected cell, with the FPV-NS1 being
found in the nucleus of the cell, the GD-NS1 being local-
ized within the cytoplasm and with the VN-NS1 occupy-
ing both intracellular locations [22,46,47]. This differential
localization could also explain the different modulation
observed for both cytokines, IFN-β and IL-1β at the tran-
scriptional (mRNA) and post-transcriptional (protein)
level.
However, while the impact of NS1 variants in the
pathogenesis of AIV in the chicken seems to fit perfectly
well with previous studies described in the literature,
their correlation with the IFN expression levels did not
seem to fit that well, at least as shown at late times post-
infection. Thus, at 48 h pi the reassortant viruses show a
similar upregulation of IFN as the FPV virus. On the
one hand, most of the previous results described for the
impact of NS1 in IFN antagonism come from in vitro
studies done with established cell lines or in vivo using
the mouse model. Agreeing with this assumption, it has
been shown that highly pathogenic avian influenza vi-
ruses do not inhibit interferon synthesis in infected
chickens [48]. On the contrary, the IFN upregulation
shown in our study was only detectable at 48 h pi and at
an RNA level, perhaps reflecting the systemic dissemin-
ation of the virus. The fact that the levels of IFN expres-
sion remain at a basal level at 6 and 24 h pi seems to
confirm the hypothesis of a real downregulation of IFN
at early time post-infection, when innate immunity
should be totally operative.
Interestingly, a very strong overexpression of IL-1β was
observed after infection with the GD and VN NS-
reassortants, detectable even in the absence of any in vitro
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the infection with the NS-reassortants might obey an in-
crease of the virus replication in monocyte-like cells and
macrophage-like cells, rather than a direct effect of the dif-
ferent NS-segments.
In fact, all samples obtained from FPV infected chick-
ens showed lower levels of IL-1β positive-cells (<10%)
than those obtained from chickens infected with the NS-
reassortant viruses. On the contrary to that described for
mice [29,30] all viruses used were highly pathogenic in
the chicken, making the comparative studies more chal-
lenging. This, together with the fact that the assay was
only performed using samples from one time-point in-
fected chickens (48 h pi), perhaps not optimal for all
AIV strains, could help to explain the lack of concord-
ance found between the percentage of IL-1β positive-
cells and virulence for the GD- and VN- reassortants.
Future quantifications of IL-1β positive-cells should also
take into account the potential leucopenia suffered by
the animals, a phenomenon that could be based on the
in vivo significance of a given percentage of IL-1β
positive-cells.
Independently of the differences found at the RNA
level, no significant differences were observed regarding
the expression of IFN-β, while significant differences
were found for IL-1β, mainly at 48 h pi. Thus, the pres-
ence of the GD- or VN-NS segment seemed to enhance
the induction of IL-1β expression, mainly by monocyte-
like and macrophage-like cells (Figure 4). IL-1β plays a
dual role for host immunity and together with IL-18
form what is named inflamasome, an essential innate
mechanism that has to be activated in order to prime
the immune system for future memory adaptive specific
responses [49]. On the contrary, IL-1β by itself has been
directly linked to autoimmune disorders and also to
immunopathogenesis after infection with all kinds of
pathogens including viruses. IL-1β is a key immunomod-
ulator cytokine that plays a multifactorial role including
two apparently opposite functions: (i) it forms part of
what has been called an inflammasome (as mentioned
above), an innate immune machinery that plays an es-
sential role to mount adaptive immune responses against
pathogens, including influenza viruses [50] and (ii) as an
antipyretic. IL-1β can be elevated immediately after the
infection with virulent avian virus strains as demonstrated
for reovirus [51] or Marek infections [52] and also as a
consequence of bacterial and virus co-infections, likely
contributing to exacerbating lesions [53].
As the main conclusions, our work demonstrates the
following: (i) that the NS segment from the H5N1 HPAIV
has an impact on the FPV pathogenesis in chickens and
(ii) that this increase in pathogenesis was coincident with
an early over-expression of IL-1β from monocyte/macro-
phage-like cells.These studies could be of utility to improve our under-
standing of the pathogenesis of HPAIV and to develop
future antiviral strategies. For example, FPV NS GD or
FPV NS VN could additionally be modified by deleting
the RNA-binding motif of the NS1 protein; thus, obtain-
ing replication-deficient, and much more immunogenic
influenza virus vaccines than those previously described
in the literature using this method [54].Additional files
Additional file 1: Distribution of NP antigen in two representative
tissues (heart and kidney) of chickens challenged with FPV, FPV NS
GD, FPV NS VN or saline solution at day 3 pi. Viral antigen was found
in myocytes (heart, left panel) and in epithelial tubular cells (kidney, right
panel) from all IAV-infected groups.
Additional file 2: Comparison of the NS1 of FPV (H7N1), GD (H5N1)
and VN (H5N1). Identical amino acids are boxed in black. The regions of
the RNA-binding domain and the effector domain are underlined by dark
blue and light blue bars, respectively.
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